Boehringer Ingelheim
Latest News
-
Race to the bottom
— May 25 2012 4:40 PM from New Statesman -
Jentadueto™ (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with Type 2 Diabetes in Europe
— May 25 2012 11:48 AM from Business Wire -
EU body wants new guidance on Boehringer clot drug
— May 25 2012 9:25 AM from Reuters -
Linagliptin safe and effective for African American patients with type 2 diabetes
— May 25 2012 5:12 AM from News-Medical.net -
New Phase 3 data for Tradjenta® (linagliptin) tablets in black or African American patients with type 2 diabetes showed significant improvement in blood sugar
— May 24 2012 1:26 PM from PR Newswire
